Cargando…
Targeted therapy in cervical cancer
Cervical cancer continues to be a common cancer in women worldwide, especially in less developed regions where advanced stage presentations are common. Addition of bevacizumab to cytotoxic chemotherapy has been the only notable recent advance in the treatment of recurrent and metastatic cervical can...
Autores principales: | Vora, Chakor, Gupta, Sudeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438352/ https://www.ncbi.nlm.nih.gov/pubmed/30997156 http://dx.doi.org/10.1136/esmoopen-2018-000462 |
Ejemplares similares
-
Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades
por: Kumar, Anuj, et al.
Publicado: (2021) -
Targeted Gene Delivery Therapies for Cervical Cancer
por: Áyen, Ángela, et al.
Publicado: (2020) -
Advances in Targeted Therapy for the Treatment of Cervical Cancer
por: Watkins, Dean E., et al.
Publicado: (2023) -
Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
por: Gupta, Sudeep
Publicado: (2019) -
Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)